Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Tax Provisions (2021 - 2023)

Silo Pharma's Tax Provisions history spans 3 years, with the latest figure at $906396.0 for Q1 2023.

  • For Q1 2023, Tax Provisions rose 50.34% year-over-year to $906396.0; the TTM value through Mar 2023 reached $1.5 million, changed N/A, while the annual FY2021 figure was $24876.0, N/A changed from the prior year.
  • Tax Provisions for Q1 2023 was $906396.0 at Silo Pharma, up from $602909.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $906396.0 in Q1 2023 and bottomed at $5743.0 in Q4 2021.
  • The 3-year median for Tax Provisions is $311021.0 (2021), against an average of $383545.2.
  • The largest YoY upside for Tax Provisions was 50.34% in 2023 against a maximum downside of 50.34% in 2023.
  • A 3-year view of Tax Provisions shows it stood at $5743.0 in 2021, then skyrocketed by 10398.15% to $602909.0 in 2022, then soared by 50.34% to $906396.0 in 2023.
  • Per Business Quant, the three most recent readings for SILO's Tax Provisions are $906396.0 (Q1 2023), $602909.0 (Q1 2022), and $5743.0 (Q4 2021).